IGM Biosciences climbs on merger deal with Concentra

Technology
IGM Biosciences climbs on merger deal with Concentra
IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out
IGM Biosciences’ stock tumbles as analysts weigh in on pivot plan with dismay
IGM Biosciences up 40% following Biogen HI-Bio buy
TD Cowen turns bullish on IGM Financial after Rockefeller Capital deal
Canadian Investment Giant IGM Could Launch Bitcoin and Ethereum Products in 2022

See which Billionaires own this investment
Type
ETF
Exchange
NYSE ARCA
Currency
US Dollar
Country Name
USA
Country ISO
US
Category
US Dollar
ISIN
US4642875490
Company Name
iShares
Inception Date
2001-03-13
Updated At
-
Total Assets
10.1B
Annual Holdings Turnover
0.09
Yield
0.13%
Dividend Paying Frequency
NA
Annual Management Charge
0.00
Ongoing Charge
0.0000
Net Expense Ratio
0.00
% Long
% Short
% Net Assets
Stock US
98.37%
0.00%
98.37%
Stock non-US
1.48%
0.00%
1.48%
Cash
0.17%
0.01%
0.16%
Other
0.00%
0.00%
0.00%
Bond
0.00%
0.00%
0.00%
Not Classified
0.00%
0.00%
0.00%
Total
100.01%
0.01%
100.00%